CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pharmacyclics LLC v. BeOne Medicines USA, Inc.

1:23-cv-00646

Overview

Case Number 1:23-cv-00646
Filing Date 2023-06-13
Status Terminated
Termination Date 2025-09-30
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

BeOne Medicines Ltd. Operating Company

Represented By

4 Attorneys Listed

Seth R. Bowers

Williams & Connolly LLP - Washington

Tel: +1 (202) 434-5000

725 Twelfth St, NW, Washington, DC 20005

Donald C. Vavala , III

Wilks Law, LLC

Tel: +1 (302) 225-0854
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

David E. Wilks

Wilks Law, LLC

Tel: +1 (302) 225-0858
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

Christopher J. Mandernach

Email: cmandernach@wc.com

BeOne Medicines USA, Inc. Operating Company

Represented By

4 Attorneys Listed

Seth R. Bowers

Williams & Connolly LLP - Washington

Tel: +1 (202) 434-5000

725 Twelfth St, NW, Washington, DC 20005

Donald C. Vavala , III

Wilks Law, LLC

Tel: +1 (302) 225-0854
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

David E. Wilks

Wilks Law, LLC

Tel: +1 (302) 225-0858
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

Christopher J. Mandernach

Email: cmandernach@wc.com

BeiGene, Ltd. Operating Company

Represented By

7 Attorneys Listed

Seth R. Bowers

Williams & Connolly LLP - Washington

Tel: +1 (202) 434-5000

725 Twelfth St, NW, Washington, DC 20005

Priyata Y. Patel

Email: priyata.patel@weil.com

Elizabeth S. Weiswasser

Email: elizabeth.weiswasser@weil.com

Donald C. Vavala , III

Wilks Law, LLC

Tel: +1 (302) 225-0854
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

David E. Wilks

Wilks Law, LLC

Tel: +1 (302) 225-0858
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

Christopher J. Mandernach

Email: cmandernach@wc.com

Anish R. Desai

Email: anish.desai@weil.com

BeiGene USA, Inc. Operating Company

Represented By

7 Attorneys Listed

Seth R. Bowers

Williams & Connolly LLP - Washington

Tel: +1 (202) 434-5000

725 Twelfth St, NW, Washington, DC 20005

Priyata Y. Patel

Email: priyata.patel@weil.com

Elizabeth S. Weiswasser

Email: elizabeth.weiswasser@weil.com

Donald C. Vavala , III

Wilks Law, LLC

Tel: +1 (302) 225-0854
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

David E. Wilks

Wilks Law, LLC

Tel: +1 (302) 225-0858
Fax: +1 (302) 225-0851

4250 Lancaster Pike, Suite 200

Christopher J. Mandernach

Email: cmandernach@wc.com

Anish R. Desai

Email: anish.desai@weil.com

Plaintiff

Pharmacyclics LLC Operating Company

Represented By

2 Attorneys Listed

Jeremy A. Tigan

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 351-9106

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 19 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (19): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11672803
Use of inhibitors of Brutons tyrosine kinase (Btk)
Filed: 2020-07-10
Issued: 2023-06-13
Active (13.6 yrs remaining)
Expires: 2040-07-10

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

10

Dispositive

0

Granted

4

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 10

Key Dispositive Motions & Rulings

Procedural / Extension Motion Granted
ORDER granting 27 Unopposed MOTION to Amend/Correct Case Caption and Notice of Company Name Change. Signed by Judge Colm F. Connolly on 6/2/2025. (mws) (Entered...
Entry #28 • 2025-06-02 Document →
Procedural / Extension Motion Granted
Unopposed MOTION to Amend/Correct Case Caption and Notice of Company Name Change - filed by BeiGene USA, Inc., BeiGene, Ltd.. (Attachments: # 1 Exhibit A, # 2 T...
Entry #27 • 2025-05-30 Document →
Procedural / Extension Motion Granted
Unopposed MOTION to Amend Case Caption and Notice of Company Name Change - filed by BeiGene USA, Inc., BeiGene, Ltd.. (Attachments: # 1 Exhibit A, # 2 Text of P...
Entry #24 • 2025-03-26 Document →
Procedural / Extension Motion Granted
ORDER granting 24 Unopposed MOTION to Amend Case Caption. Signed by Judge Colm F. Connolly on 3/26/2025. (mws) (Entered: 03/26/2025)
Entry #25 • 2025-03-26 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Plaintiff Pharmacyclics LLC to answer, move, or otherwise respond to Defendants' Counterclaims to October 23, 2023 - filed by Pha...
Entry #18 • 2023-10-04 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 18 STIPULATION TO EXTEND TIME for Plaintiff Pharmacyclics LLC to answer, move, or otherwise respond to Defendants' Counterclaims to October 23, 2...
Entry #— • 2023-10-04

Docket Entries

(51 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against BeiGene USA, Inc., BeiGene, Ltd. ( Filing fee $ 402, receipt number ADEDC-4157589.) - filed by Pharmacyclics LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 06/13/2023)

Entry #1 • 2023-06-13
1
Pleading / Complaint

COMPLAINT filed with Jury Demand against BeiGene USA, Inc., BeiGene, Ltd. ( Filing fee $ 402, receipt number ADEDC-4157589.) - filed by Pharmacyclics LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 06/13/2023)

Entry #1 • 2023-06-13
2
Pleading / Complaint

COMPLAINT filed with Jury Demand against BeiGene USA, Inc., BeiGene, Ltd. ( Filing fee $ 402, receipt number ADEDC-4157589.) - filed by Pharmacyclics LLC. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(apk) (Entered: 06/13/2023)

Entry #1 • 2023-06-13
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 06/13/2023)

Entry #2 • 2023-06-13
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,672,803 B2. (apk) (Entered: 06/13/2023)

Entry #3 • 2023-06-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc